Showing 1181 - 1190 of 1263 for "Dispute%20resolution" with applied filters
19 September 2017 by
This week's moves came at Hicksons, Johnson Winter & Slattery, Corrs Chambers Westgarth, Thomson Geer and DibbsBarker in Australia, while IndusLaw added two partners to its Hyderabad team.
05 September 2017 by
Latest updates from Hong Kong, Singapore, India and more
01 September 2017 by
New Balance has won in a trade mark infringement dispute in a first instance decision from the Suzhou Intermediate People’s Court. The court ordered the defendants to pay damages and legal costs of RMB10 million ($1.47 million) in a case involving the use of the shoemaker’s slanting logo.
18 August 2017 by
President Trump has authorised an inquiry into China’s alleged theft of the intellectual property of US companies. While some believe this to be Trump’s way of forcing China to increase pressure against North Korea to stop developing nuclear weapons, others think Trump’s concern about how IP theft is affecting US businesses is genuine.
14 August 2017 by
Cheers! New Zealand now accepts geographical indications (GIs) registration for wines and spirits. Launched just last month, the register allows brand owners to register a product from a particular geographic region if it has certain characteristics or qualities attributed to the location. Famous GIs from other parts of the world include Scotch whisky and champagne.
03 August 2017 by
Latest partner moves from India, Australia and Singapore
28 July 2017 by
Policymakers, academics and lawyers at a conference in Hong Kong last month spoke of the “immense opportunities” for investors in Asia in sectors such as transport and energy generation under the One Belt One Road (OBOR) initiative. They warned, however, that investors in the 65 countries along the route of OBOR must be aware of the risks in putting their money into emerging economies that may not be equipped with robust legal frameworks.
27 July 2017 by
The China Food and Drug Administration (CFDA) is planning to introduce a patent linkage scheme that will require a generic applicant to make a non-infringement declaration against an innovator’s patent portfolio. By creating this linkage, innovators can rest assured that their innovations are protected while generic drug companies are motivated to get regulatory approval for entry into market by proving that a patent is invalid or not infringed. However, observers warn of potential challenges in implementation.
26 July 2017 by
Latest partner moves from Singapore, Indonesia and more
05 July 2017 by
The research for this year’s Asialaw Asia-Pacific Dispute Resolution Awards 2017 is complete and the shortlists will be available on this page soon.